4//SEC Filing
Dulac Edward J III 4
Accession 0001209191-23-041607
CIK 0001434316other
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 5:18 PM ET
Size
4.8 KB
Accession
0001209191-23-041607
Insider Transaction Report
Form 4
Dulac Edward J III
Chief Financial Officer
Transactions
- Sale
Common Stock
2023-07-05$4.83/sh−5,182$25,029→ 124,288 total
Footnotes (1)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 5, 2023.
Documents
Issuer
FATE THERAPEUTICS INC
CIK 0001434316
Entity typeother
Related Parties
1- filerCIK 0001821530
Filing Metadata
- Form type
- 4
- Filed
- Jul 5, 8:00 PM ET
- Accepted
- Jul 6, 5:18 PM ET
- Size
- 4.8 KB